Top News

Lumena Pharmaceuticals Acquired By Shire

San Diego-based biopharmaceuticals developer Lumena Pharmaceuticals has been acquired by UK-based Shire plc, in a deal worth $260M plus earn out, the companies said this morning. Shire said the buy would help add to its rare diseases portfolio. Lumena Pharmaceuticals had filed for an IPO in April; the company was venture backed by Alta Partners, New Enterprise Associates, RiverVest, A.M. Pappas Life Sciences Ventures, and Adage Capital Partners.


 

Marketplace


 

 

Latest Headlines

Browse Issues

 
 

Keep up with all of the latest Southern California high tech news via email (it's free!)



or Cancel